抗小鼠PD-1单克隆抗体(克隆号RMP1-14.1) ，体内实验级重组，小鼠IgG2c- LALAPG Kappa | Syd Labs PA007162.m2cLA

描述

PA007162.m2cLA: Syd Labs体内实验级重组抗小鼠PD-1单克隆抗体（克隆号RMP1-14.1），小鼠IgG2c-L234A L235A P329G (LALAPG) Kappa（In Vivo Grade Recombinant Anti-mouse PD-1 Monoclonal Antibody （Clone RMP1-14.1），Mouse IgG2c-L234A L235A P329G (LALAPG) Kappa）

抗小鼠PD-1单抗（RMP1-14）部分参考文献:

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent.
Grasselly, C., et al. Front Immunol. 2018 Oct 9;9:2100. doi: 10.3389/fimmu.2018.02100. PMID: 30356816
Immune checkpoint inhibitors (ICI), such as anti-PD-1 (Programmed cell death 1) or anti-PD-L1 (Programmed death-ligand 1) antibodies, are among the most important recent breakthroughs in oncology. …The PD-1/PD-L1 axis induces an inhibitory signal in T cells, and PD-1/PD-L1 pathway blockade restores T cell function resulting in increased proliferation and cytotoxic activity, subsequently improving anti-tumor immune response. …For this reason, it is crucial to develop new therapeutic approaches to enhance the therapeutic effects of PD-1/PD-L1 blockade, and to avoid resistance phenomena. …We performed an exploratory study of various combination regimens of chemotherapies with immune checkpoint blockers anti-PD-1 and anti-PD-L1, in several murine syngeneic preclinical models. …T cell infiltrates were increased after exposure to chemotherapy + anti-PD-1, to a stronger extent in the 4T1 model than in the MC38 model.
Tags: anti-mouse PD-1 RMP1-14; anti-mouse PD-1 RMP1-14 mAb

TGF? Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity.
Vanpouille-Box, C., et al. Cancer Res. 2015 Jun 1;75(11):2232-42. doi: 10.1158/0008-5472.CAN-14-3511. PMID: 25858148
Although adaptive immune resistance that developed in responding tumors limited the efficacy of this approach, it could be overcome by additional blockade of the immune checkpoint receptor PD-1. …Anti-PD-1 RMP1-14 mAb was purchased from BioXCell. …In some experiments, anti-PD-1 mAb RMP1-14 was injected i.p. (200 ug/mouse) on days 18, 22, 26, and 30. …Because interactions between the immune checkpoint receptor PD-1 and its ligands PD-L1 and PD-L2 are an important mechanism inhibiting tumor rejection by T cells (39), we next investigated the expression of PD-1 and its ligands in the tumor. …RT given with either TGF? or PD-1 blockade improved control of the irradiated tumor with 44% and 25% complete regressions, respectively, and a significant extension of survival (P < 0.001 compared with control and RT), but in both groups, all tumors recurred before day 40.
Tags: anti-mouse PD-1 RMP1-14 antibody in vivo; anti-mouse PD-1 RMP1-14 mAb in vivo

A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1.
Ngiow, S. F., et al. Cancer Res. 2015 Sep 15;75(18):3800-11. doi: 10.1158/0008-5472.CAN-15-1082. PMID: 26208901
Purified anti-mouse PD1 mAb (RMP1-14), anti-mouse Tim3 (RMT3-23), anti-mouse PDL1 (10F.9G2), and control Ig (2A3) were purchased from BioXCell and used in the schedule and dose as indicated. …Tumor growth was measured using a digital caliper, and tumor sizes are presented as mean ± SEM. At indicated time points, tumors were weighed and recorded (mg) for individual mice in each group. …For Foxp3+ Treg depletion, 500 ng of DT (200 uL volume) was intraperitoneally injected in MC38- or AT3-bearing Foxp3-DTR transgenic mice at the indicated time, and an equal volume of PBS was used as a control. …Tumors and peripheral lymphoid tissues were harvested from mice that had been treated with mAb or otherwise and processed for flow cytometric analysis as previously described. …Statistical analyses were conducted using GraphPad Prism software.
Tags: anti-mouse PD-1 RMP1-14 antibody in animal model; anti-mouse PD-1 RMP1-14 mAb in animal model

了解更多抗小鼠PD-1单克隆抗体（clone：RMP1-14）参考文献，请查看：抗小鼠PD-1单抗（克隆号RMP1-14）参考文献

Syd Labs抗小鼠PD-1小鼠IgG2c-LALAPG重组抗体（克隆号RMP1-14.1）（货号：PA007162.m2cLA）推荐同型对照抗体:

重组小鼠IgG2c-LALAPG同型对照抗体，体内实验级（In Vivo Grade Recombinant Mouse IgG2c-L234A L235A P329G (LALAPG) Isotype Control Antibody）

Syd Labs提供以下抗小鼠PD 1抗体（anti-mouse PD 1 antibodies）:

体内实验级重组抗小鼠PD1单克隆抗体（克隆号29F.1A12.1）（In vivo grade recombinant anti-mouse PD1 monoclonal antibodies （Clone 29F.1A12.1））
体内实验级重组抗小鼠PD-1单克隆抗体（克隆号RMP1-14.1）（In vivo grade recombinant anti-mouse PD-1 monoclonal antibodies （Clone RMP1-14.1））
体内实验级重组鼠化抗小鼠PD 1单克隆抗体（In Vivo Grade Recombinant Murinized Anti-mouse PD-1 Mouse Monoclonal Antibody (Clone RMP1-14.1) 

Syd Labs还提供以下体内实验级重组抗小鼠PD-1单克隆抗体(克隆号RMP1-14.1)突变体:

体内实验级重组抗小鼠PD-1单克隆抗体(克隆号RMP1-14.1)，小鼠IgG2a-LALAPG Kappa
体内实验级重组抗小鼠PD-1单克隆抗体(克隆号RMP1-14.1)，小鼠IgG1-D265A Kappa

关于PA007162.m2cLA Syd Labs抗小鼠PD 1抗体您可能还会搜索:

PA007162.r2a Syd Labs抗小鼠PD1抗体
PA007162.m2cLA Syd Labs抗小鼠PD 1抗体
PA007162.m2aLA Syd Labs抗小鼠PD-1抗体
PA007162.m1DA Syd Labs
PA007162.m2a RMP1-14
PA007162.rt Syd Labs
PA007162.m2c 多找找
PA007162.m1 RMP1-14
be0146 bioxcell

背景知识

The rat anti-mouse PD-1 monoclonal antibody （大鼠抗小鼠PD-1单克隆抗体）（clone No. RMP1-14, rat IgG2a kappa）reacts with the mouse PD-1 protein (抗小鼠CD279抗体 or programmed death-1) encoded by the mouse pdcd1 gene, a member of the CD28 family of the Ig superfamily. PD-1 has two ligands, PD-L1 and PD-L2, both of which belong to the B7 family. It has been shown that in mouse models of melanoma, tumor growth can be transiently arrested via treatment with the anti-mouse PD 1 antibody and the anti-mouse PD L1 antibody which block the interaction between the PD-L1 protein and its receptor PD-1 protein. The RMP1-14 antibody blocks the binding of both the mouse PD-L1 protein and the mouse PD-L2 protein to the mouse PD-1 protein.

Our recombinant RMP1-14 antibodies （重组抗小鼠CD279单克隆抗体）have a part (variable regions) or complete amino acid sequences of the rat anti-mouse PD-1 antibody（大鼠抗小鼠PD-1抗体） （hybridoma clone name or number: RMP1-14）. The murinized anti-mouse PD-1 recombinant antibody has not only the constant regions of the mouse IgG antibodies but also the murinized variable regions.

重组抗小鼠PD 1抗体（RMP1-14 PA007162.m2cLA）相关问答:

Question: Which anti-mouse PD1 antibody works the best?
Answer: (by AI) There are several anti-mouse PD1 antibodies available in the market: Clones RMP1-14, 29F.1A12, and J43. All three of these antibodies are commonly used to block PD-1 signaling in vivo in murine tumor models and other mouse models. These three clones all have extensive multi-year publication records supporting them. The RMP1-14 antibody has been reported to block the binding of PD-1 to its ligands (B7-H1 and B7-DC) and to inhibit T cell proliferation and cytokine production costimulated by macrophages (but not by dendritic cells and B cells). (by Syd Labs) Syd Labs offers anti-mouse PD-1 monoclonal antibodies（抗小鼠PD-1单克隆抗体） based on the sequences of clones RMP1-14 and 29F.1A12. Syd Labs provides in vivo grade recombinant antibodies including engineered antibodies for the clones RMP1-14 and 29F.1A12. Even though mouse and rat are close, rat antibodies may still induce immunogenecity in mice. Antibodies with murinized variable regions and mouse constant regions behave like humanized antibody drugs in animal models using mice. In addition, the mouse IgG2c antibody is produced in certain inbred strains such as C57BL/6, C57BL/10, SJL, and NOD, which does not express the mouse IgG2a antibody（小鼠IgG2a抗体）; the mouse IgG2a antibody（小鼠IgG2a抗体） is produced in other inbred strains such as BALB/c and Swiss Webster mice, which does not express the mouse IgG2c antibody（小鼠IgG2c抗体）. If one uses the C57BL/6 mouse strain for animal model research, it is better to use the IgG2c antibodies rather than the IgG2a antibodies. The format with the Fc silenced, Fc silent, or Fcs with silenced effector function, such as LALAPG mutation, is the most popular for anti-mouse PD1 antibodies（抗小鼠PD1抗体）（clones RMP1-14 and 29F.1A12） and anti-mouse PD-L1 antibodies（抗小鼠PD-L1抗体）（clone 10F.9G2）.

Question: Do you produce any recombinant Fc-silenced RMP1-14 antibody（重组Fc-silenced RMP1-14抗体）?
Answer: Sure, we provide various recombinant Fc silent RMP1-14 antibodies（重组Fc silent RMP1-14抗体）, such as mIgG2c LALAPG, mIgG2a LALAPG, and mIgG1 D265A. We also provide custom recombinant antibody production service to produce other engineered versions of recombinant RMP1-14 antibodies（RPM1-14单抗抗小鼠PD 1）. We have a promotion program running: We provide 1 mg PA007162.m2cLA （In Vivo Grade Recombinant Anti-mouse PD-1 Mouse IgG2c-LALAPG Kappa Monoclonal Antibody（体内实验级重组抗小鼠PD-1小鼠IgG2c-LALAPG Kappa单克隆抗体）（Clone RMP1-14.1）） for free in exchange of results. Please contact us to know more about the free RMP1-14 antibody.

Question: What is the difference among PA007162.r2a, PA007162.m2cLA, and PA007162.mm2cLA?
Answer: PA007162.r2a is the recombinant anti-mouse PD-1 monoclonal antibody（重组抗小鼠PD-1单克隆抗体） （rat IgG2a kappa, clone RMP1-14.1） produced in CHO cells or HEK293 cells if needed. It has the same variable region and constant region sequences as the rat anti-mouse PD-1 monoclonal antibody（大鼠抗小鼠PD-1单克隆抗体） from the hybridoma clone of RMP1-14. Rat antibodies may cause high immuogenicity in mice; thus, at least recombinant antibodies with mouse antibody constant regions should be used to replace the rat antibody constant regions. PA007162.m2cLA is the recombinant anti-mouse PD-1 antibody（重组抗小鼠PD-1抗体）（clone RMP1-14.1） whose constant regions are mouse IgG2c LALAPG kappa. We further murinize the antibody variable region sequences of PA007162.m2cLA to produce PA007162.mm2cLA.

请记住我们的产品信息: Syd Labs（货号：PA007162.m2cLA）体内实验级重组抗小鼠PD-1单克隆抗体(克隆RMP1-14.1)，小鼠IgG2c-L234A L235A P329G (LALAPG) Kappa: PA007162.m2cLA Syd Labs In Vivo Grade Recombinant Anti-mouse PD-1 Monoclonal Antibody (Clone RMP1-14.1), Mouse IgG2c-L234A L235A P329G (LALAPG) Kappa。